CADL

Candel Therapeutics (CADL)

‌

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$8.19

Daily low

$7.80

Price at open

$8.09

52 Week High

$14.60

52 Week Low

$1.34

Market cap

359.8M

Dividend yield

0.00%

Volume

458,747

Avg. volume

1.4M

P/E ratio

-4.65

Candel Therapeutics News